bioRxivImmunology
The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A Nephropathy
C. Huang, X. Li, J. Wu, W. Zhang, S. Sun, L. Lin, X. Wang, H. Li, X. Wu, P. Zhang, G. Xu, H. Wan, H. Liu, Y. Liu, D. Chen, L. Zhuo, H. Yang, J. Wang, L. Wang, X. Liu
Abstract
Immunoglobulin A Nephropathy (IgAN) is the most common glomerulonephritis worldwide. In IgAN, immune complex deposite in glomerular mesangium, which induce inflammation and affect the kidneys normal functions. However, the exact pathogenesis of IgAN is still incompletely understood. Further, in current practice the clinical diagnosis relies on needle biopsy on renal tissue. Therefore, a non-invasive method for clinical diagnosis and prognosis surveillance of the disease is in high demand. In this paper, we investigated both the T cell receptor bata chain (TCRB) and immunoglobulin heavy chain (IGH) repertoire of kidney infiltrating and circulating lymphocytes of IgAN patients by immune repertoire high throughput sequencing. We found that the features of TCRB and IGH in the renal tissues were remarkably different from that in blood, including a decreased repertoire diversity and increased IgA and IgG frequency, and more activated B cells. The CDR3 length of PBMC TCRB and IGH in patients is significantly shorter than that in healthy controls, which is the result of both VDJ rearrangement and clone selection. We also found that the IgA1 frequency in the PBMC of IgAN is significant higher than that in other Nephropathy (NIgAN) and healthy control, which is consistent with the previous reports on the level of IgA1 producing B cells and serum IgA1. Significantly, we identified a set of IgAN disease related TCRB and IGH CDR3s, which can be used to distinguish IgAN from NIgAN and healthy controls from the blood with high accuracy. These results indicated that TCRB and IGH repertoire can potentially serve as non-invasive biomarkers for IgAN diagnosis. The characteristics of kidney infiltrating and circulating lymphocytes repertoire shed light on IgAN detection, treatment and surveillance.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of inflammatory biomarkers in IgA nephropathy using the NanoString technology: a validation study
Laurence Gaumond, Caroline Lamarche, … Louis‐Philippe Laurin·bioRxiv·Sep 11, 2023
- Blockade of mTOR ameliorates IgA Nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice
Alexandra Cambier, Jennifer Da Silva, … Renato C. Monteiro·PLoS ONEPeer-reviewed·Oct 7, 2025
- Evidences of histologic Thrombotic Microangiopathy and the impact in renal outcomes of patients with IgA nephropathy
P. D. M. d. M. Neves, R. A. Souza, … L. B. Jorge·bioRxiv·May 1, 2020
- Identifying Therapeutic Strategies in IgA Nephropathy through Comprehensive Transcriptomic Characterization
Kenneth Ofori, Amin Yakubu, Alex J. Rai·bioRxiv·Aug 18, 2021
- Mucosal Inflammation as a Driver of Gd-IgA1 Production in IgA Nephropathy: Mechanistic Support for Targeted Therapies
Kateřina Zachová, Alica Cutkova, … Milan Raška·bioRxiv·Oct 24, 2026
- Multi-Omics Characterization of Plasma and Urine Extracellular Vesicles Identifies Non-Invasive Biomarkers for IgA Nephropathy
Yi‐Cheng Lin, Tanyu Chang, … C C K Chih-Chin Kao·bioRxiv·Jul 17, 2026